Marijuana Stocks Are Absolutely Exploding

[rado]

does everyone in RI look and sound like peter griffin? that's how i picture that little no name state. do they allow coloreds and mexicans in RI?

No bro lol

RI is like being in Italy, almost.

Accents are worse on people from CT.

Latin community is large, but Italians and sicilians definitely crush it here.

Sent from my SM-G955U using Tapatalk

[Bouncer]

No bro lol

RI is like being in Italy, almost.

Accents are worse on people from CT.

Latin community is large, but Italians and sicilians definitely crush it here.

Sent from my SM-G955U using Tapatalk

Sounds like a good place to me. Make America great again! :D

Sent from my Moto G6 using Tapatalk

[Bouncer]

It’s pleasing to see a country has taken the floor away from drug traffickers and made them selves a shit load of tax revenue st the same time

Well said.

Sent from my Moto G6 using Tapatalk

[rado]

Sounds like a good place to me. Make America great again! :D

Sent from my Moto G6 using Tapatalk

No doubt you'd love it here, I fucking do.

I know I've said this many times, but the food here(all of it, especially Italian) is just THAT good.

And people here are true assholes; these fuckers will fight quick lol.

If you man up in RI, better be laced up and ready to throw down. In Boston? Lol that's funny[emoji39]

Sent from my SM-G955U using Tapatalk

[jolter604]

For those that have any interest in stocks you should at least take a look at the Canadian marijuana sector. It's been going nuts for the last month. Marijuana goes fully legal in 6 weeks and big American alcohol and tobacco companies are buying in big. CGC was $5 just 2 months ago, it's now $52 dollars. That's over a 10x gain and it's not slowing down. You can trade these companies on American stock exchanges under (CGC), (CRON), and (TLRY).

_______________________________




3 Reasons Big Tobacco and Marijuana Partnerships Are Imminent

https://finance.yahoo.com/news/3-rea...html?.tsrc=rss

The green rush is in full force. Beginning in less than six weeks, recreational marijuana will be completely legal in Canada. Aside from Canada becoming the first developed country in the world, and second overall, to wave the proverbial green flag on adult-use weed, this move could also generate upwards of $5 billion in added annual revenue once the industry is running on all cylinders.

Dealmaking ramps up as legalization inches closer
Legalizing weed in our neighbor to the north has also spurred a lot of dealmaking activity both outside and within the cannabis industry. Within the industry, leading producer Aurora Cannabis, which is expected to yield 570,000 kilograms a year once fully operational, acquired CanniMed Therapeutics and Ontario-based MedReleaf for $852 million and approximately $2.5 billion, respectively.

But what's happening outside the industry is what has investors' full attention. Last month, we witnessed two major partnerships take place between Big Alcohol and the cannabis industry. On Aug. 1, Molson Coors Brewing announced the formation of a 57.5%-42.5% joint venture with HEXO Corp (previously known as Hydropothecary Corp) to develop nonalcoholic, cannabis-infused beverages. Interestingly enough, infused beverages won't be legal come Oct. 17, although Canada's Parliament is expected to discuss, and likely broaden, what forms of consumption are legal next year.

Making even bigger headlines was Constellation Brands' (NYSE:STZ) $3.8 billion equity investment in Canopy Growth Corp (NYSE:CGC) at a 51% premium to its prior-day closing price on Aug. 15. This was actually the third time the maker of the Corona and Modelo beer brands had invested in Canopy Growth. Aside from just product innovation, Constellation should be able to offer its marketing and international expansion expertise to Canopy Growth, while Canopy will be able to offer its insight into the cannabis industry to Constellation Brands.

A Big Tobacco-marijuana marriage appears inevitable
Though most investors have wondered what alcohol company could be next -- rumor has it that Diageo is looking for a cannabis partner -- they might be overlooking the next-most logical entrant into the cannabis space: Big Tobacco.

Here are three reasons a Big Tobacco-marijuana partnership appears inevitable.

1. Key tobacco metrics are declining in developed markets
The biggest impetus for Big Tobacco to seek out a partnership or investment opportunity with the marijuana industry is declining usage and shipment volume in developed markets. Within the U.S., the percentage of U.S. adults smoking cigarettes has declined from around 42% in the mid-1960s to just 15.5% as of 2016. The industry is also facing marketing, advertising, and branding restrictions in key developed markets around the globe.

For example, Altria (NYSE:MO), which is best known for its premium Marlboro brand in the U.S., reported a 6.3% sales decline in smokable products during the second quarter of 2018, as well as a 3.7% decline through the first half of the year. Overall, Altria's smokable domestic shipment volume wound up plunging 10.8%.

Meanwhile, Philip Morris International (NYSE:PM), which operates in more than 180 countries around the world, not including the U.S., saw its total cigarette shipment volume fall by 1.5% in the second quarter, and 3.3% through the first half of the year. In fact, with the exception of its Fortune and Dji Sam Soe brands, every other cigarette brand has delivered a volume decline during the first half of 2018.

2. Big Tobacco has more than enough capital to make a deal happen
Another good reason to believe a deal should happen between Big Tobacco and cannabis is that Big Tobacco has more than enough cash on hand, and operating cash flow, to make it happen.

Despite the fact that volume has been in constant decline for Altria and more recently Philip Morris, both tobacco companies offer incredible pricing power as a result of nicotine's addictive nature. For instance, even though Philip Morris experienced a 3.3% slide in cigarette shipments during the first half of the year, it still managed to grow revenue by 8.3%, if you exclude the benefit of currency movements. Being able to pass along price hikes to consumers has long been a means to higher sales and profitability for tobacco stocks.

But the thing is, Big Tobacco also needs to innovate and find new ways to grow. For as long as this investor can recall, Altria and Philip Morris have paid out enormous dividends to lure in long-term investors. Yet, these companies are still generating a lot of annual operating cash flow. Altria has averaged about $5 billion annually over the past five years, with Philip Morris generating closer to $8.5 billion over the same time frame. That's more than enough to divert some of this cash flow to an investment or joint venture in the cannabis industry.

3. It's a logical product evolution
Finally, Big Tobacco partnering with the marijuana industry would be a logical evolution of where the tobacco industry is already headed.

Earlier this decade, the introduction of electronic cigarettes were all the rage. More recently, heated tobacco units, such as Philip Morris' iQOS device, have been garnering attention. The point being that Big Tobacco has been working on ways to lessen its reliance on traditional dried tobacco for years, and what the cannabis industry is trying to accomplish would be complementary to the tobacco industry's goals.

For example, assuming the Canadian federal government approves new forms of consumption in 2019, beyond just dried cannabis and cannabis oils, vaporized cannabis cartridges could be used in existing devices that consumers have been using for vape products, or perhaps even with heated tobacco units. It would be a relatively seamless transition for both the tobacco and cannabis industries, and should be beneficial to both.

Great post Bouncer!


[email protected]

pct-shop.com

[Bouncer]

Marlboro cigarette maker Altria Group Inc (MO.N) is in early stage talks to acquire Canadian cannabis producer Cronos Group Inc (CRON.TO), as it seeks to diversify its business beyond traditional smokers, people familiar with the matter said on Monday.

Canada this year legalized recreational use of marijuana and is seen as a testing ground for pot companies that expect to expand globally as other countries follow suit.

Cronos has not agreed to any deal and there is no certainty it will do so, the sources said. The discussions between Cronos and Altria are expected to last for several weeks, one of the sources added.

The sources asked not to be identified because the matter is confidential. Altria did not immediately respond to a request for comment, while Cronos declined to comment.

Cronos shares listed on the Nasdaq rose 23 percent to $11.32 in Monday afternoon trading after Reuters reported on the deal talks, giving Cronos a market value of more than $2 billion.

Other Canadian cannabis stocks also jumped. Tilray Inc (TLRY.O) shares rose 4 percent, while New Age Beverages Corp (NBEV.O) shares soared 10 percent.

A deal would mark one of the largest combinations between mainstream tobacco and the booming but volatile marijuana sector, which has seen interest from a variety of major consumer companies that are monitoring the industry for disruptive threats and faster-growing product possibilities.

In June, London-based tobacco company Imperial Brands Plc (IMB.L) took an undisclosed stake in closely held Oxford Cannabinoid. Constellation Brands Inc. announced a $3.8 billion investment in Canopy Growth Corp (WEED.TO) in August, while Coca-Cola Co (KO.N) said in September it was watching the space for alliances that could potentially help it develop products containing cannabinoid oil.

Altria’s shares have fallen by more than 20 percent over the year, as cigarette smoking continues to decline in the United States. Federal data from earlier this month showed cigarette smoking among U.S. adults reached an estimated 14 percent in 2017, the lowest level ever.

Altria has invested in the e-cigarette sector in recent years through its Nu Mark subsidiary. It is also in talks to take a minority stake of between 20 and 40 percent in e-cigarette maker Juul Labs Inc, sources said last week.

Big tobacco companies such as Altria have been investing in e-cigarettes as U.S. tobacco smoking rates decline.

https://www.reuters.com/article/us-c...-idUSKBN1O2225

[Mr I]

Glad I brought this to sm years ago

[Bouncer]

Altria to invest $1.8 billion in cannabis company Cronos Group, exits some e-cig brands

Altria Group will buy a 45 percent stake in leading cannabinoid company Cronos Group for about $1.8 billion.

Altria will discontinue MarkTen and Green Smoke e-cigarette products and its Verve oral nicotine.

The company is still weighing an investment in e-cigarette company Juul, and talks could conclude as soon as later this month, a person familiar with the situation tells CNBC.

The steps are a sign of the new world in which Altria must compete.

https://www.cnbc.com/2018/12/07/altr...nos-group.html

[Bouncer]

Once the stock market is done crashing and stocks start to bounce up again, CGC, ACB, and Tilray will 5x (probably more) in a short period of time. This will be a bigger rise then crypto but unlike crypto the use case is real and it's not a market filled with garbage. These companies are exploding and the potential is almost unlimited.

Tilray and Budweiser new partnership

https://www.marketwatch.com/story/ti...nks-2018-12-19